| Date | Company Name | Action | Current
Price | Price
Target | Rating | Impact on
Share Price |
|---|
| 10/21/2024 | GILD Gilead Sciences | Upgrade | $88.00 | $74.00 ➝ $96.00 | Market Perform ➝ Outperform | Low |
| 10/18/2024 | LXRX Lexicon Pharmaceuticals | Set Price Target | $2.00 | $6.00 | Outperform ➝ Outperform | Low |
| 10/18/2024 | TNYA Tenaya Therapeutics | Reiterated Rating | $2.00 | | Outperform ➝ Outperform | Low |
| 10/18/2024 | AMLX Amylyx Pharmaceuticals | Set Price Target | $5.00 | $4.00 | Market Perform ➝ Market Perform | High |
| 10/17/2024 | MASS 908 Devices | Lower Price Target | $3.00 | $15.00 ➝ $12.00 | Outperform ➝ Outperform | Medium |
| 10/17/2024 | GH Guardant Health | Lower Price Target | $20.00 | $60.00 ➝ $50.00 | Outperform ➝ Outperform | High |
| 10/17/2024 | BBIO BridgeBio Pharma | Lower Price Target | $25.00 | $47.00 ➝ $46.00 | Outperform ➝ Outperform | Low |
| 10/17/2024 | VCYT Veracyte | Boost Price Target | $33.00 | $35.00 ➝ $40.00 | Outperform ➝ Outperform | Low |
| 10/17/2024 | MIRM Mirum Pharmaceuticals | Boost Price Target | $40.00 | $47.00 ➝ $49.00 | Outperform ➝ Outperform | Low |
| 10/17/2024 | TWST Twist Bioscience | Boost Price Target | $44.00 | $45.00 ➝ $48.00 | Market Perform ➝ Market Perform | Medium |
| 10/17/2024 | RVTY Revvity | Boost Price Target | $119.00 | $130.00 ➝ $135.00 | Outperform ➝ Outperform | Low |
| 10/17/2024 | NTRA Natera | Boost Price Target | $120.00 | $140.00 ➝ $150.00 | Outperform ➝ Outperform | Medium |
| 10/17/2024 | ILMN Illumina | Boost Price Target | $144.00 | $160.00 ➝ $200.00 | Outperform ➝ Outperform | Low |
| 10/17/2024 | ISRG Intuitive Surgical | Boost Price Target | $518.00 | $489.00 ➝ $502.00 | | Low |
| 10/16/2024 | VYGR Voyager Therapeutics | Initiated Coverage | $6.00 | $15.00 | Outperform | High |
| 10/16/2024 | WVE Wave Life Sciences | Boost Price Target | $15.00 | $20.00 ➝ $22.00 | Outperform ➝ Outperform | High |
| 10/14/2024 | MNMD Mind Medicine (MindMed) | Initiated Coverage | $6.00 | $20.00 | Outperform | High |
| 10/14/2024 | STOK Stoke Therapeutics | Initiated Coverage | $13.00 | $18.00 | Outperform | High |
| 10/8/2024 | VINC Vincerx Pharma | Lower Price Target | $0.00 | $4.00 ➝ $2.00 | Outperform ➝ Outperform | High |
| 10/8/2024 | TVTX Travere Therapeutics | Reiterated Rating | $18.00 | $20.00 ➝ $20.00 | Outperform ➝ Outperform | Medium |
| 10/8/2024 | HOLX Hologic | Lower Price Target | $82.00 | $95.00 ➝ $90.00 | Outperform ➝ Outperform | Low |
| 10/7/2024 | COR Cencora | Lower Price Target | $234.00 | $277.00 ➝ $275.00 | Outperform ➝ Outperform | Low |
| 10/7/2024 | MCK McKesson | Lower Price Target | $505.00 | $665.00 ➝ $630.00 | Outperform ➝ Outperform | Low |
| 10/2/2024 | HUM Humana | Downgrade | $262.00 | $400.00 ➝ $250.00 | Outperform ➝ Market Perform | High |
| 9/30/2024 | AQST Aquestive Therapeutics | Reiterated Rating | $5.00 | $10.00 ➝ $12.00 | Outperform ➝ Outperform | High |
| 9/27/2024 | AGIO Agios Pharmaceuticals | Downgrade | $45.00 | $60.00 ➝ $56.00 | Outperform ➝ Market Perform | High |
| 9/24/2024 | REGN Regeneron Pharmaceuticals | Reiterated Rating | $962.00 | $1,175.00 ➝ $1,077.00 | Outperform ➝ Market Perform | High |
| 9/23/2024 | BHVN Biohaven | Boost Price Target | $53.00 | $55.00 ➝ $60.00 | Outperform ➝ Outperform | Low |
| 9/20/2024 | SPRY ARS Pharmaceuticals | Boost Price Target | $17.00 | $21.00 ➝ $25.00 | Outperform ➝ Outperform | Low |
| 9/19/2024 | APLT Applied Therapeutics | Boost Price Target | $9.00 | $11.00 ➝ $14.00 | Outperform ➝ Outperform | Low |
| 9/19/2024 | FDMT 4D Molecular Therapeutics | Reiterated Rating | $8.00 | $40.00 ➝ $36.00 | Outperform ➝ Outperform | High |
| 9/19/2024 | PGNY Progyny | Lower Price Target | $16.00 | $25.00 ➝ $21.00 | Market Perform ➝ Market Perform | High |
| 9/18/2024 | ICLR ICON Public | Initiated Coverage | $283.00 | $379.00 | Outperform | High |
| 9/17/2024 | ORKA Oruka Therapeutics | Initiated Coverage | $30.00 | $44.00 | Outperform | Low |
| 9/17/2024 | MRNA Moderna | Lower Price Target | $53.00 | $60.00 ➝ $48.00 | Underperform ➝ Underperform | Medium |
| 9/12/2024 | FULC Fulcrum Therapeutics | Reiterated Rating | $3.00 | $4.00 | Outperform ➝ Market Perform | N/A |
| 9/10/2024 | INSP Inspire Medical Systems | Boost Price Target | $198.00 | $167.00 ➝ $197.00 | Market Perform ➝ Market Perform | Low |
| 9/9/2024 | IMUX Immunic | Reiterated Rating | $1.00 | $5.00 | Outperform | Low |
| 9/9/2024 | TRVI Trevi Therapeutics | Initiated Coverage | $3.00 | $6.00 ➝ $7.00 | Outperform | High |
| 9/9/2024 | GERN Geron | Initiated Coverage | $4.00 | $7.00 | Outperform | Medium |
| 9/9/2024 | IRWD Ironwood Pharmaceuticals | Initiated Coverage | $4.00 | $5.00 | Market Perform | High |
| 9/9/2024 | MNKD MannKind | Initiated Coverage | $7.00 | $7.00 ➝ $8.00 | Outperform | Medium |
| 9/9/2024 | PLRX Pliant Therapeutics | Initiated Coverage | $15.00 | $46.00 ➝ $33.00 | Outperform | Low |
| 9/9/2024 | PRTC PureTech Health | Initiated Coverage | $21.00 | $58.00 ➝ $45.00 | Outperform | High |
| 9/9/2024 | GLPG Galapagos | Initiated Coverage | $30.00 | $24.00 | Market Perform | High |
| 9/9/2024 | KYMR Kymera Therapeutics | Reiterated Rating | $48.00 | $60.00 | Outperform | Medium |
| 9/5/2024 | MCK McKesson | Lower Price Target | $505.00 | $670.00 ➝ $665.00 | Outperform ➝ Outperform | Low |
| 9/3/2024 | RXRX Recursion Pharmaceuticals | Lower Price Target | $7.00 | $9.00 ➝ $8.00 | Market Perform ➝ Market Perform | Low |
| 9/3/2024 | TXG 10x Genomics | Initiated Coverage | $15.00 | $35.00 | Outperform | Low |
| 9/3/2024 | NARI Inari Medical | Initiated Coverage | $44.00 | $47.00 | Market Perform | Low |
| 9/3/2024 | PCVX Vaxcyte | Boost Price Target | $113.00 | $106.00 ➝ $153.00 | Outperform ➝ Outperform | Low |
| 9/3/2024 | PEN Penumbra | Initiated Coverage | $206.00 | $263.00 | Outperform | Low |
| 8/16/2024 | VIRX Viracta Therapeutics | Downgrade | $0.00 | $5.00 ➝ $3.00 | Outperform ➝ Market Perform | Low |
| 8/12/2024 | SPRY ARS Pharmaceuticals | Boost Price Target | $17.00 | $19.00 ➝ $20.00 | Outperform | Low |
| 8/12/2024 | ARDT Ardent Health Partners | Initiated Coverage | $19.00 | $23.00 | Outperform | Low |
| 8/12/2024 | ARCT Arcturus Therapeutics | Initiated Coverage | $20.00 | $70.00 | Outperform | Low |
| 8/7/2024 | PGNY Progyny | Downgrade | $16.00 | $31.00 ➝ $25.00 | Outperform ➝ Market Perform | Low |
| 8/6/2024 | TBPH Theravance Biopharma | Downgrade | $9.00 | $15.00 ➝ $10.00 | Outperform ➝ Market Perform | Low |
| 8/1/2024 | RCM R1 RCM | Downgrade | $14.00 | $17.00 ➝ $14.30 | Outperform ➝ Market Perform | Low |
| 8/1/2024 | WAT Waters | Upgrade | $339.00 | $325.00 ➝ $375.00 | Market Perform ➝ Outperform | Low |
| 7/24/2024 | TECX Tectonic Therapeutic | Initiated Coverage | $36.00 | $49.00 | Outperform | Low |
| 7/24/2024 | IONS Ionis Pharmaceuticals | Upgrade | $39.00 | $53.00 ➝ $62.00 | Market Perform ➝ Outperform | Low |
| 7/24/2024 | DHR Danaher | Boost Price Target | $261.00 | $275.00 ➝ $280.00 | Outperform | Low |
| 7/24/2024 | HCA HCA Healthcare | Boost Price Target | $408.00 | $367.00 ➝ $396.00 | Outperform ➝ Outperform | Low |
| 7/23/2024 | ALMS Alumis | Initiated Coverage | $13.00 | $29.00 | Outperform | Low |
| 7/22/2024 | BNTC Benitec Biopharma | Initiated Coverage | $11.00 | $13.00 | Outperform | Low |
| 7/22/2024 | CELC Celcuity | Initiated Coverage | $16.00 | $29.00 | Outperform | Low |
| 7/11/2024 | LNTH Lantheus | Boost Price Target | $113.00 | $106.00 ➝ $127.00 | Outperform ➝ Outperform | Low |
| 7/10/2024 | EHC Encompass Health | Initiated Coverage | $95.00 | $100.00 | Outperform | Low |
| 7/9/2024 | HLVX HilleVax | Downgrade | $2.00 | $28.00 ➝ $2.00 | Outperform ➝ Market Perform | Low |
| 7/8/2024 | RVTY Revvity | Initiated Coverage | $119.00 | $125.00 | Outperform | Low |
| 7/2/2024 | SDGR Schrödinger | Initiated Coverage | $19.00 | $29.00 | Outperform | Low |
| 6/27/2024 | COR Cencora | Reiterated Rating | $234.00 | $275.00 ➝ $275.00 | Outperform ➝ Outperform | Low |
| 6/25/2024 | ALNY Alnylam Pharmaceuticals | Boost Price Target | $296.00 | $138.00 ➝ $159.00 | Market Perform ➝ Market Perform | Low |
| 6/24/2024 | SLDB Solid Biosciences | Upgrade | $6.00 | $12.00 ➝ $12.00 | Market Perform ➝ Outperform | Low |
| 6/24/2024 | SRPT Sarepta Therapeutics | Boost Price Target | $128.00 | $165.00 ➝ $230.00 | Outperform ➝ Outperform | Low |
| 6/20/2024 | MREO Mereo BioPharma Group | Boost Price Target | $4.00 | $6.00 ➝ $8.00 | Outperform ➝ Outperform | Low |
| 5/21/2024 | QTTB Q32 Bio | Initiated Coverage | $47.00 | $54.00 | Outperform | Low |
| 5/15/2024 | BOLT Bolt Biotherapeutics | Reiterated Rating | $1.00 | $3.00 ➝ $1.00 | Outperform ➝ Market Perform | Low |
| 5/14/2024 | AIRS AirSculpt Technologies | Downgrade | $6.00 | $8.25 ➝ $5.00 | Outperform ➝ Market Perform | Low |
| 5/14/2024 | EHAB Enhabit | Upgrade | $7.00 | $8.50 | Underperform ➝ Market Perform | Low |
| 5/10/2024 | AQST Aquestive Therapeutics | Initiated Coverage | $5.00 | $8.00 | Outperform | Low |
| 5/8/2024 | MYGN Myriad Genetics | Upgrade | $23.00 | $25.00 ➝ $35.00 | Market Perform ➝ Outperform | Low |
| 5/6/2024 | BPMC Blueprint Medicines | Upgrade | $86.00 | $50.00 ➝ $97.00 | Underperform ➝ Market Perform | Low |
| 5/1/2024 | CVS CVS Health | Reiterated Rating | $57.00 | $87.00 ➝ $60.00 | Outperform ➝ Market Perform | Low |
| 4/30/2024 | LXRX Lexicon Pharmaceuticals | Initiated Coverage | $2.00 | $5.00 | Outperform | Low |
| 4/29/2024 | XOMA XOMA | Initiated Coverage | $29.00 | $40.00 | Outperform | Low |
| 4/29/2024 | NGNE Neurogene | Initiated Coverage | $50.00 | $46.00 | Outperform | Low |
| 4/29/2024 | IMCR Immunocore | Initiated Coverage | $33.00 | $74.00 | Outperform | Low |
| 4/25/2024 | CVAC CureVac | Downgrade | $3.00 | $12.00 ➝ $4.00 | Outperform ➝ Market Perform | Low |
| 4/25/2024 | TNDM Tandem Diabetes Care | Upgrade | $34.00 | $34.00 ➝ $45.00 | Market Perform ➝ Outperform | Low |
| 4/23/2024 | RNAC Cartesian Therapeutics | Initiated Coverage | $22.00 | $39.00 | Outperform | Low |
| 4/16/2024 | ANAB AnaptysBio | Initiated Coverage | $35.00 | $47.00 | Outperform | Low |
| 4/15/2024 | MNMD Mind Medicine (MindMed) | Initiated Coverage | $6.00 | $20.00 | Outperform | Low |
| 4/15/2024 | LENZ LENZ Therapeutics | Initiated Coverage | $25.00 | $32.00 | Outperform | Low |
| 4/5/2024 | ARDX Ardelyx | Initiated Coverage | $6.00 | $14.00 | Outperform | Low |
| 4/3/2024 | LRMR Larimar Therapeutics | Initiated Coverage | $8.00 | $25.00 | Outperform | Low |
| 4/1/2024 | NUVL Nuvalent | Upgrade | $103.00 | $69.00 ➝ $110.00 | Market Perform ➝ Outperform | Low |
| 3/25/2024 | SGMT Sagimet Biosciences | Initiated Coverage | $6.00 | $26.00 | Outperform | Low |
| 3/18/2024 | RGLS Regulus Therapeutics | Initiated Coverage | $1.00 | $6.00 | Outperform | Low |
